Does the Monocyte Count/HDL Cholesterol Ratio predict Cardiovascular Disease in patients with Obstructive Sleep Apnea Syndrome?
The Monocyte Count/HDL Cholesterol Ratio (MHR) may serve as a useful biomarker to predict cardiovascular disease in patients with obstructive sleep apnea syndrome.
The MHR is strongly associated with CVD and the severity of OSAS and might be used as a biomarker to predict CVD in patients with OSAS.
Köseoğlu et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: